3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Hepatoblastoma
1
Hemangioma, Cavernous, Central Nervous System
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
16
Filgrastim
15
Etoposide
10
Carboplatin
10
Peripheral Blood Stem Cell Transplantation
8
Melphalan
8
Magnetic Resonance Spectroscopy
7
Granulocyte Colony-Stimulating Factor
7
Busulfan
7
Thiotepa
6
Temozolomide
6
Radiotherapy
6
Ifosfamide
6
etoposide phosphate
5
X-Rays
5
Topotecan
5
Phantoms, Imaging
5
Doxorubicin
5
Cisplatin
5
Vincristine
4
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Mesna
4
selpercatinib
3
sargramostim
3
pembrolizumab
3
palbociclib
3
aldesleukin
3
Sirolimus
3
Radiosurgery
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Simvastatin
×
CNS
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled